Company Filing History:
Years Active: 2023
Title: Joseph Daniel Ho: Innovator in Diabetes Treatment
Introduction
Joseph Daniel Ho is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of diabetes treatment through his innovative research and development efforts. His work focuses on glucagon-like peptide-1 receptor agonists, which play a crucial role in managing type II diabetes mellitus.
Latest Patents
Joseph Daniel Ho holds a patent for glucagon-like peptide-1 receptor agonists. This patent includes a compound of a specific formula or a pharmaceutically acceptable salt thereof, along with methods for using this compound to treat type II diabetes mellitus. His innovative approach has the potential to improve the lives of many individuals suffering from this condition. He has 1 patent to his name.
Career Highlights
Joseph is currently employed at Eli Lilly and Company, a leading pharmaceutical company known for its commitment to advancing healthcare. His role at Eli Lilly allows him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Throughout his career, Joseph has worked alongside talented colleagues, including David Andrew Coates and Todd Fields. These collaborations have fostered an environment of innovation and creativity, leading to advancements in diabetes treatment.
Conclusion
Joseph Daniel Ho is a dedicated inventor whose work in glucagon-like peptide-1 receptor agonists represents a significant advancement in diabetes treatment. His contributions at Eli Lilly and Company and his collaborations with esteemed colleagues highlight his commitment to improving healthcare outcomes.